CVS, Walgreens and Rite Aid suspend sale of Zantac over potential cancer risk
CVS, Walgreens and Rite Aid are pulling Zantac, and the generic form of the popular heartburn medication from shelves, over a potential cancer risk.
•
Oct 1, 2019, 9:46 AM
•
Updated 1,998 days ago
Share:
CVS, Walgreens and Rite Aid are pulling Zantac, and the generic form of the popular heartburn medication from shelves, over a potential cancer risk.
According to U.S. health regulators, there's a potentially dangerous carcinogen in prescription and over-the-counter versions of the drug.
Despite the decision to stop selling the medicine, the products have not been recalled.
CVS customers can return them for a full refund.
There is no word yet on possible refunds from the other pharmacy chains.
More from News 12
2:00
Congestion pricing deadline extended last minute. What it means for NJ.
1:47
WIND ALERT: Strong wind gusts precede a pleasant weekend in New Jersey
USGS: 1.8 magnitude earthquake shakes part of Somerset County
3:53
Tree falls on to school bus in Tewksbury
2:20
Paws and Pals: Serrano is ready for a new start
2:01
